Metabolix, Inc.  

(Public, NASDAQ:MBLX)   Watch this stock  
Find more results for MBLX
0.000 (0.00%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.70 - 0.82
52 week 0.54 - 3.98
Open 0.82
Vol / Avg. 191,821.00/29,928.00
Mkt cap 21.13M
P/E     -
Div/yield     -
EPS -0.93
Shares 27.73M
Beta 3.24
Inst. own 10%
May 13, 2016
Q1 2016 Metabolix Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -962.67% -912.91%
Operating margin -963.11% -915.30%
EBITD margin - -905.09%
Return on average assets -188.26% -117.75%
Return on average equity -258.00% -148.82%
Employees 68 -
CDP Score - -


19 Presidential Way Ste 201
WOBURN, MA 01801-1184
United States - Map
+1-617-5831700 (Phone)
+1-617-5831768 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Metabolix, Inc. is an advanced biomaterials company. The Company operates through the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants segment. The Company is focused on delivering solutions to the plastics industry. The Company has its operations in the microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. The Company is focused on a family of biopolymers found in nature called polyhydroxyalkanoates (PHAs), which occur naturally in living organisms and are chemically similar to polyesters. The Company is also focusing on applications where the performance, biodegradability, biocontent and other attributes of its PHA biopolymers provide functional advantages, such as biodegradation, required by such applications, including PHA resins for molded articles and films, as well as PHA latex and other PHA coatings for paper and cardboard.

Officers and directors

Robert L. Van Nostrand Chairman of the Board, Independent Director
Age: 58
Bio & Compensation  - Reuters
Joseph H. Shaulson President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Johan van Walsem Chief Operating Officer
Age: 52
Bio & Compensation  - Reuters
Charles B. Haaser Chief Accounting Officer
Age: 59
Bio & Compensation  - Reuters
Oliver P. Peoples Ph.D. Chief Scientific Officer, Director
Age: 57
Bio & Compensation  - Reuters
Lynne H. Brum Vice President - Marketing and Corporate Communications
Age: 51
Bio & Compensation  - Reuters
Sarah P. Cecil General Counsel, Secretary
Age: 63
Bio & Compensation  - Reuters
Peter N. Kellogg Independent Director
Age: 60
Bio & Compensation  - Reuters
Celeste B. Mastin Independent Director
Bio & Compensation  - Reuters
Anthony J. Sinskey Ph.D. Independent Director
Age: 75
Bio & Compensation  - Reuters